Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Gadola

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|January 15, 2003
Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infectionMichaela Lucas, Stephan Gadola, Ute Meier, et al.
Journal of Shoulder and Elbow Surgery|September 6, 2012
Motor control retraining exercises for shoulder impingement: effects on function, muscle activation, and biomechanics in young adultsPeter Worsley, Martin Warner, Sarah Mottram, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2016
Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from functionYifang Gao, Peter D Arkwright, Rachel Carter, et al.
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infectionAndrew Chancellor, Andrew White, Anna S Tocheva, et al.
Blood|November 8, 2003
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patientsGal Markel, Huda Mussaffi, Khoon-Lin Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
CD1b-restricted GEM T cell responses are modulated by <i>Mycobacterium tuberculosis</i> mycolic acid meromycolate chainsAndrew Chancellor, Anna S Tocheva, Chris Cave-Ayland, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|January 15, 2003
Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infectionMichaela Lucas, Stephan Gadola, Ute Meier, et al.
Journal of Shoulder and Elbow Surgery|September 6, 2012
Motor control retraining exercises for shoulder impingement: effects on function, muscle activation, and biomechanics in young adultsPeter Worsley, Martin Warner, Sarah Mottram, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2016
Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from functionYifang Gao, Peter D Arkwright, Rachel Carter, et al.
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infectionAndrew Chancellor, Andrew White, Anna S Tocheva, et al.
Blood|November 8, 2003
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patientsGal Markel, Huda Mussaffi, Khoon-Lin Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
CD1b-restricted GEM T cell responses are modulated by <i>Mycobacterium tuberculosis</i> mycolic acid meromycolate chainsAndrew Chancellor, Anna S Tocheva, Chris Cave-Ayland, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Pageof 2